Reminyl Gets New Name – Razadyne – Ahead Of ER Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
The name change for the Alzheimer's product follows reports of medication errors with Sanofi-Aventis' diabetes product Amaryl. J&J agreed to change the name prior to launching the extended-release version of galantamine, which will be available in pharmacies in May.